1
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Cancer Treat Res. 152:3–13. 2010. View Article : Google Scholar
|
2
|
Chou AJ and Gorlick R: Chemotherapy
resistance in osteosarcoma: current challenges and future
directions. Expert Rev Anticancer Ther. 6:1075–1085. 2006.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Entz-Werlé N, Lavaux T, Metzger N, et al:
Involvement of MET/TWIST/APC combination or the potential role of
ossification factors in pediatric high-grade osteosarcoma
oncogenesis. Neoplasia. 9:678–688. 2007.PubMed/NCBI
|
4
|
Stoetzel C, Weber B, Bourgeois P,
Bolcato-Bellemin AL and Perrin-Schmitt F: Dorso-ventral and
rostro-caudal sequential expression of M-twist in the
postimplantation murine embryo. Mech Dev. 51:251–263. 1995.
View Article : Google Scholar : PubMed/NCBI
|
5
|
el Ghouzzi V, Le Merrer M, Perrin-Schmitt
F, et al: Mutations of the TWIST gene in the Saethre-Chotzen
syndrome. Nat Genet. 15:42–46. 1997.
|
6
|
Entz-Werlé N, Choquet P, Neuville A, et
al: Targeted apc;twist double-mutant mice: a new model of
spontaneous osteosarcoma that mimics the human disease. Transl
Oncol. 3:344–353. 2010.PubMed/NCBI
|
7
|
Le Deley MC, Guinebretière J, Gentet JC,
et al: SFOP OS94: a randomised trial comparing preoperative
high-dose methotrexate plus doxorubicin to high-dose methotrexate
plus etoposide and ifosfamide in osteosarcoma patients. Eur J
Cancer. 43:752–761. 2007.PubMed/NCBI
|
8
|
Nelson J, Bagnato A, Battistini B and
Nisen P: The endothelin axis: emerging role in cancer. Nat Rev
Cancer. 3:110–116. 2003. View
Article : Google Scholar : PubMed/NCBI
|
9
|
Felx M, Guyot MC, Felx M, Guyot MC, Isler
M, Turcotte RE, Doyon J, Khatib AM, Leclerc S, Moreau A and
Moldovan F: Endothelin-1 (ET-1) promotes MMP-2 and MMP-9 induction
involving the transcription factor NF-kappaB in human osteosarcoma.
Clin Sci (Lond). 110:645–654. 2006. View Article : Google Scholar : PubMed/NCBI
|
10
|
Zhao Y, Liao Q, Zhu Y and Long H:
Endothelin-1 promotes osteosarcoma cell invasion and survival
against cisplatin-induced apoptosis. Clin Orthop Relat Res.
469:3190–3199. 2011. View Article : Google Scholar : PubMed/NCBI
|
11
|
Matsuo N, Shiraha H, Fujikawa T, et al:
Twist expression promotes migration and invasion in hepatocellular
carcinoma. BMC Cancer. 9:2402009. View Article : Google Scholar : PubMed/NCBI
|
12
|
Okamura H, Yoshida K and Haneji T:
Negative regulation of TIMP1 is mediated by transcription factor
TWIST1. Int J Oncol. 35:181–186. 2009.PubMed/NCBI
|
13
|
Funato N, Ohtani K, Ohyama K, Kuroda T and
Nakamura M: Common regulation of growth arrest and differentiation
of osteo-blasts by helix-loop-helix factors. Mol Cell Biol.
21:7416–7428. 2001. View Article : Google Scholar : PubMed/NCBI
|
14
|
Guenou H, Kaabeche K, Dufour C, Miraoui H
and Marie PJ: Down-regulation of ubiquitin ligase Cbl induced by
twist haploinsufficiency in Saethre-Chotzen syndrome results in
increased PI3K/Akt signaling and osteoblast proliferation. Am J
Pathol. 169:1303–1311. 2006. View Article : Google Scholar : PubMed/NCBI
|
15
|
Kim YJ, Koo TY, Yang WS, Han NJ, Jeong JU,
Lee SK and Park SK: Activation of spleen tyrosine kinase is
required for TNF-α-induced endothelin-1 upregulation in human
aortic endothelial cells. FEBS Lett. 586:818–826. 2012.
|
16
|
Wang X, Ling MT, Guan XY, Tsao SW, Cheung
HW, Lee DT and Wong YC: Identification of a novel function of
TWIST, a bHLH protein, in the development of acquired taxol
resistance in human cancer cells. Oncogene. 23:474–482. 2004.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Sun P, Xiong H, Kim TH, Ren B and Zhang Z:
Positive inter-regulation between β-catenin/T cell factor-4
signaling and endothelin-1 signaling potentiates proliferation and
survival of prostate cancer cells. Mol Pharmacol. 69:520–531.
2006.
|
18
|
Zhao Y, Liao Q, Zhu Y and Long H:
Endothelin-1 promotes osteosarcoma cell invasion and survival
against cisplatin-induced apoptosis. Clin Orthop Relat Res.
469:3190–3199. 2011. View Article : Google Scholar : PubMed/NCBI
|
19
|
Wu MH, Lo JF, Kuo CH, et al: Endothelin-1
promotes MMP-13 production and migration in human chondrosarcoma
cells through FAK/PI3K/Akt/mTOR pathways. J Cell Physiol.
227:3016–3026. 2012. View Article : Google Scholar : PubMed/NCBI
|
20
|
Kulasekaran P, Scavone CA, Rogers DS,
Arenberg DA, Thannickal VJ and Horowitz JC: Endothelin-1 and
transforming growth factor-beta1 independently induce fibroblast
resistance to apoptosis via AKT activation. Am J Respir Cell Mol
Biol. 41:484–493. 2009. View Article : Google Scholar : PubMed/NCBI
|
21
|
Rosenberg B, Vancamp L, Trosko JE and
Mansour VH: Platinum Compounds: a new class of potent antitumour
agents. Nature. 222:385–386. 1969. View
Article : Google Scholar : PubMed/NCBI
|